Komar M - Search Results

1

Effects of Coumarinyl Schiff Bases against Phytopathogenic Fungi, the Soil-Beneficial Bacteria and Entomopathogenic Nematodes: Deeper Insight into the Mechanism of Action.

Rastija V, Vrandečić K, Ćosić J, Šarić GK, Majić I, Agić D, Šubarić D, Karnaš M, Bešlo D, Komar M, Molnar M. Rastija V, et al. Among authors: komar m. Molecules. 2022 Mar 28;27(7):2196. doi: 10.3390/molecules27072196. Molecules. 2022. PMID: 35408596 Free PMC article.

2

Deep Eutectic Solvents as Convenient Media for Synthesis of Novel Coumarinyl Schiff Bases and Their QSAR Studies.

Molnar M, Komar M, Brahmbhatt H, Babić J, Jokić S, Rastija V. Molnar M, et al. Among authors: komar m. Molecules. 2017 Sep 5;22(9):1482. doi: 10.3390/molecules22091482. Molecules. 2017. PMID: 28872604 Free PMC article.

3

Environmentally Friendly Approach to Knoevenagel Condensation of Rhodanine in Choline Chloride: Urea Deep Eutectic Solvent and QSAR Studies on Their Antioxidant Activity.

Molnar M, Brahmbhatt H, Rastija V, Pavić V, Komar M, Karnaš M, Babić J. Molnar M, et al. Among authors: komar m. Molecules. 2018 Jul 29;23(8):1897. doi: 10.3390/molecules23081897. Molecules. 2018. PMID: 30060629 Free PMC article.

4

Application of Deep Eutectic Solvents in the Synthesis of Substituted 2-Mercaptoquinazolin-4(3H)-Ones: A Comparison of Selected Green Chemistry Methods.

Komar M, Kraljević TG, Jerković I, Molnar M. Komar M, et al. Molecules. 2022 Jan 16;27(2):558. doi: 10.3390/molecules27020558. Molecules. 2022. PMID: 35056873 Free PMC article.

5

Experimental and computational evaluation of dipeptidyl peptidase III inhibitors based on quinazolinone-Schiff's bases.

Agić D, Karnaš M, Tomić S, Komar M, Karačić Z, Rastija V, Bešlo D, Šubarić D, Molnar M. Agić D, et al. Among authors: komar m. J Biomol Struct Dyn. 2023 Sep-Oct;41(16):7567-7581. doi: 10.1080/07391102.2022.2123044. Epub 2022 Sep 15. J Biomol Struct Dyn. 2023. PMID: 36106968

6

Antifungal Activities of Fluorinated Pyrazole Aldehydes on Phytopathogenic Fungi, and Their Effect on Entomopathogenic Nematodes, and Soil-Beneficial Bacteria.

Rastija V, Vrandečić K, Ćosić J, Kanižai Šarić G, Majić I, Agić D, Šubarić D, Karnaš M, Bešlo D, Brahmbhatt H, Komar M. Rastija V, et al. Among authors: komar m. Int J Mol Sci. 2023 May 26;24(11):9335. doi: 10.3390/ijms24119335. Int J Mol Sci. 2023. PMID: 37298285 Free PMC article.

7

Environmentally Friendly Approach to the Synthesis of 3-[Benzylideneamino]-2-methylquinazolin-4(3H)-one Derivatives and Calculation of Their Toxicity.

Molnar M, Gazivoda Kraljević T, Pavić V, Rastija V, Komar M. Molnar M, et al. Among authors: komar m. Chem Biodivers. 2023 Aug;20(8):e202300575. doi: 10.1002/cbdv.202300575. Epub 2023 Jul 24. Chem Biodivers. 2023. PMID: 37417922

8

Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease.

Nowicki M, Bazan-Socha S, Błażejewska-Hyżorek B, Kłopotowski MM, Komar M, Kusztal MA, Liberek T, Małyszko J, Mizia-Stec K, Oko-Sarnowska Z, Pawlaczyk K, Podolec P, Sławek J; Polish Fabry Disease Collaborative Group. Nowicki M, et al. Among authors: komar m. Orphanet J Rare Dis. 2024 Mar 28;19(1):139. doi: 10.1186/s13023-024-03140-x. Orphanet J Rare Dis. 2024. PMID: 38549140 Free PMC article. No abstract available.

9

Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trial.

Groten T, Lehmann T, Städtler M, Komar M, Winkler JL, Condic M, Strizek B, Seeger S, Jäger Y, Pecks U, Eckmann-Scholz C, Kagan KO, Hoopmann M, von Kaisenberg CS, Hertel B, Tauscher A, Schrey-Petersen S, Friebe-Hoffmann U, Lato K, Hübener C, Delius M, Verlohren S, Sroka D, Schlembach D, de Vries L, Kraft K, Seliger G, Schleußner E; PETN study group. Groten T, et al. Among authors: komar m. Am J Obstet Gynecol MFM. 2024 Mar 7;6(4):101332. doi: 10.1016/j.ajogmf.2024.101332. Online ahead of print. Am J Obstet Gynecol MFM. 2024. PMID: 38460823 Free article.

10

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.

Dreyfus J, Komar M, Attias D, De Bonis M, Ruschitzka F, Popescu BA, Laroche C, Tribouilloy C, Bogachev Prokophiev A, Mizariene V, Bax JJ, Maggioni AP, Messika-Zeitoun D, Vahanian A, Iung B; on behalf of the EORP VHD II Registry Investigators Group. Dreyfus J, et al. Among authors: komar m. Eur J Heart Fail. 2024 Feb 19. doi: 10.1002/ejhf.3157. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38374610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page